top of page
Search

Dr. Seva Katritch Received a Major UG3/UH3 Grant Award

  • Writer: QCB at USC
    QCB at USC
  • Sep 1
  • 1 min read

Dr. Seva Katritch received a major UG3/UH3 grant award from the National Institute of Neurological Disorders and Stroke to continue the development of AT2 receptor inhibitor as a preclinical candidate for neuropathic pain treatment. The drug candidate was discovered and optimized using the computer-driven platform developed in the lab. More details can be found here.

 
 
 

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page